| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 2.34e-03 | 71 | 19 | 2 | 1.10.418.10 | |
| Domain | CH | 2.47e-03 | 73 | 19 | 2 | PS50021 | |
| Domain | Ig_2 | 2.47e-03 | 73 | 19 | 2 | PF13895 | |
| Domain | CH-domain | 2.60e-03 | 75 | 19 | 2 | IPR001715 | |
| Domain | Ubiquitin-rel_dom | 1.48e-02 | 184 | 19 | 2 | IPR029071 | |
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 21880741 | ||
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 12361972 | ||
| Pubmed | Nkx6.1 controls migration and axon pathfinding of cranial branchio-motoneurons. | 8.61e-05 | 24 | 20 | 2 | 14534138 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.14e-04 | 877 | 20 | 5 | 20211142 | |
| Pubmed | 3.94e-04 | 51 | 20 | 2 | 16919471 | ||
| Pubmed | 4.14e-04 | 257 | 20 | 3 | 30945288 | ||
| Cytoband | 11p15.1 | 3.14e-04 | 60 | 20 | 2 | 11p15.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.80e-03 | 564 | 20 | 3 | chr11p15 | |
| Coexpression | DE_YY1_TARGETS_UP | 1.04e-04 | 20 | 20 | 2 | M2462 | |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 2.72e-04 | 168 | 20 | 3 | M6874 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_PRONEURAL | 3.17e-04 | 177 | 20 | 3 | M2115 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 3.17e-04 | 177 | 20 | 3 | M39245 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 3.63e-04 | 37 | 20 | 2 | M16643 | |
| Coexpression | GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 3.73e-04 | 187 | 20 | 3 | M8460 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP | 3.78e-04 | 188 | 20 | 3 | M5648 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 3.83e-04 | 38 | 20 | 2 | M39244 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_SUBVENTRICULAR_ZONE | 4.03e-04 | 39 | 20 | 2 | MM441 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 4.09e-04 | 193 | 20 | 3 | M3303 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 4.34e-04 | 197 | 20 | 3 | M4421 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 4.40e-04 | 198 | 20 | 3 | M4415 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 4.46e-04 | 41 | 20 | 2 | M39320 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP | 4.47e-04 | 199 | 20 | 3 | M8115 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN | 4.53e-04 | 200 | 20 | 3 | M5073 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP | 4.53e-04 | 200 | 20 | 3 | M9953 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN | 4.53e-04 | 200 | 20 | 3 | M8033 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN | 4.53e-04 | 200 | 20 | 3 | M9285 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.69e-07 | 163 | 20 | 4 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.69e-07 | 163 | 20 | 4 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.19e-06 | 182 | 20 | 4 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 194 | 20 | 4 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.57e-06 | 195 | 20 | 4 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 159 | 20 | 3 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 5.37e-05 | 166 | 20 | 3 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 5.37e-05 | 166 | 20 | 3 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | mild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.47e-05 | 167 | 20 | 3 | 0811f7559c2a7151693771e52e14af3978997118 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-05 | 169 | 20 | 3 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.76e-05 | 170 | 20 | 3 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 5.76e-05 | 170 | 20 | 3 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-45|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-05 | 170 | 20 | 3 | e028e22ad051c2628248b212b5d28b891e0ee782 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-05 | 171 | 20 | 3 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 5.86e-05 | 171 | 20 | 3 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | Control-CD4+_T_activated|World / Disease group and Cell class | 6.07e-05 | 173 | 20 | 3 | 12f8e4276b290bb388a56de4c8d8dd60415b2f63 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.07e-05 | 173 | 20 | 3 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.17e-05 | 174 | 20 | 3 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.28e-05 | 175 | 20 | 3 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 6.61e-05 | 178 | 20 | 3 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 178 | 20 | 3 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.72e-05 | 179 | 20 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-05 | 181 | 20 | 3 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.06e-05 | 182 | 20 | 3 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.06e-05 | 182 | 20 | 3 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.17e-05 | 183 | 20 | 3 | dbc7ec66da5930c2bf4e0405937b054e04c22a34 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.41e-05 | 185 | 20 | 3 | cc5152d3055375172bdf84f442b233c8fbd422b3 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.41e-05 | 185 | 20 | 3 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 7.41e-05 | 185 | 20 | 3 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | IIF-Lymphocyte-B-B_naive|IIF / Disease, Lineage and Cell Type | 7.41e-05 | 185 | 20 | 3 | dec48908addfc71f32f5ce0ce73f2926e476f60b | |
| ToppCell | ICU-NoSEP-Myeloid-pDC|ICU-NoSEP / Disease, Lineage and Cell Type | 7.41e-05 | 185 | 20 | 3 | 7564a47df4a4e3af30d40aa0f48bd9d9c82358ae | |
| ToppCell | BLOOD--(2)_Naive_B_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.53e-05 | 186 | 20 | 3 | 2e55a3892459152fc4a3a7834ccbf5d71b65d29a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.53e-05 | 186 | 20 | 3 | 0dce13e15c3bf32610bf2dad31253b52a39cff87 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.53e-05 | 186 | 20 | 3 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-05 | 187 | 20 | 3 | c10d6a774b3e83f64e47b9ad08f5d6b0dc60d163 | |
| ToppCell | IIH-pDC-|IIH / Condition, Cell_class and T cell subcluster | 7.65e-05 | 187 | 20 | 3 | ad87b146ea8dd9f695e722f8f0e8e1057c7f3167 | |
| ToppCell | Tuft-tuft-2|World / Class top | 7.65e-05 | 187 | 20 | 3 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|World / Lineage, cell class and subclass | 7.65e-05 | 187 | 20 | 3 | 904ffd8cf4513e86fcd4c2b7faf24a34fbd2dce3 | |
| ToppCell | IIF-Lymphocyte-B|IIF / Disease, Lineage and Cell Type | 7.65e-05 | 187 | 20 | 3 | bba950ad8f4cd9be416516043724fc22786d879e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-05 | 187 | 20 | 3 | d01926be1c8846a25fb6706e26b56b808b69f8f0 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 7.65e-05 | 187 | 20 | 3 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.65e-05 | 187 | 20 | 3 | 160e5f338537d90d50f863a1be801b1071ac7da7 | |
| ToppCell | lymphoid-B_cell|World / Lineage, cell class and subclass | 7.65e-05 | 187 | 20 | 3 | 2abbc01fd7f5b4e52113699625287893c991f8da | |
| ToppCell | IIH-pDC|IIH / Condition, Cell_class and T cell subcluster | 7.65e-05 | 187 | 20 | 3 | 5e59e9153a18bcfb5c8dc94599080216661de7ce | |
| ToppCell | Leuk-UTI-Myeloid-pDC|Leuk-UTI / Disease, Lineage and Cell Type | 7.65e-05 | 187 | 20 | 3 | e3035b1f65ab12b8f01799b8e5d6633b9b584a06 | |
| ToppCell | 10x5'-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue | 7.77e-05 | 188 | 20 | 3 | 2b3560b28f9df6f4d4a3e0a4acfa6c7d964ad0fe | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.77e-05 | 188 | 20 | 3 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.77e-05 | 188 | 20 | 3 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.77e-05 | 188 | 20 | 3 | 26405ef1b934744e672c642db78834c21d3ba28f | |
| ToppCell | 10x5'-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 7.89e-05 | 189 | 20 | 3 | 9837dca502c9a7f42efb0bc74f3e88e7461e7dc8 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 7.89e-05 | 189 | 20 | 3 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.89e-05 | 189 | 20 | 3 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.89e-05 | 189 | 20 | 3 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.02e-05 | 190 | 20 | 3 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.02e-05 | 190 | 20 | 3 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.02e-05 | 190 | 20 | 3 | 441770ce7b3c81f36f5b15b8e51794f736462457 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-05 | 190 | 20 | 3 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 190 | 20 | 3 | 112706d64ee73b55dcf76f33ca064ab1fc6ce87f | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 190 | 20 | 3 | adffa93635da10251f28b2089fd96b189775c8b4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 190 | 20 | 3 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 190 | 20 | 3 | 9a91bf1ea105029e6412d0d9060bca325299ce26 | |
| ToppCell | MS-pDC|MS / Condition, Cell_class and T cell subcluster | 8.02e-05 | 190 | 20 | 3 | f41d7ab7d7fbcd73fddb6c3533c6a3e642e3d07f | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.02e-05 | 190 | 20 | 3 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 190 | 20 | 3 | 39c8ddc2639bf3e986dae11fbae61a735614b604 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 190 | 20 | 3 | a95aea3aa707fc4574810706341a5f32b3d00209 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 190 | 20 | 3 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.02e-05 | 190 | 20 | 3 | 18dfa84c62dcf081ce9958a71e76a394ec0968e4 | |
| ToppCell | MS-pDC-|MS / Condition, Cell_class and T cell subcluster | 8.02e-05 | 190 | 20 | 3 | f56ec302d556ace4f7609017a35c311cf43aa8a5 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 190 | 20 | 3 | 2c1c079fd411c03bc3f383aa927eea9446716960 | |
| ToppCell | (4)_B_mantle|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.14e-05 | 191 | 20 | 3 | 5dab7f26c59838080787efad963b9cfcfa9a5f13 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.14e-05 | 191 | 20 | 3 | a831e30f37aff329d83fac9bdb84f783075d5df6 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.14e-05 | 191 | 20 | 3 | b374676ac90572d65895052d46469906e2b6fd93 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 8.14e-05 | 191 | 20 | 3 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.14e-05 | 191 | 20 | 3 | 8c487704cbbb5eeff54e8c6fb6fffa1472b5351f | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.14e-05 | 191 | 20 | 3 | 78d523f562d32fc408a20d99b0c61cc103241bc0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.14e-05 | 191 | 20 | 3 | 2453064c39b359088d43d52792bf829f83442c82 | |
| ToppCell | (100)_CD19+_Naive_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 8.27e-05 | 192 | 20 | 3 | ae7e6ed7b6cc1dd45bc0547783515beecad7792a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.27e-05 | 192 | 20 | 3 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 8.27e-05 | 192 | 20 | 3 | fa99243ff028498c6a67d207a93e02c48e69cd42 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 8.27e-05 | 192 | 20 | 3 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.40e-05 | 193 | 20 | 3 | 4fbf559771c367a6f5a03e0a5ef33366c118ddbf | |
| ToppCell | normal-na-Lymphocytic_B|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.40e-05 | 193 | 20 | 3 | 5fe436b8da06c537b61d18aba8a24b0c8b1895bb | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.40e-05 | 193 | 20 | 3 | cf4ba50aa4a00d1ba22fc7626d49a4104377d5d9 | |
| ToppCell | normal-na-Lymphocytic_B-B_naive|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.40e-05 | 193 | 20 | 3 | 98279a3c69f1df062c4a8333e46c8fd649bf86b1 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 8.40e-05 | 193 | 20 | 3 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 193 | 20 | 3 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 8.40e-05 | 193 | 20 | 3 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.40e-05 | 193 | 20 | 3 | dd199163fc13f3d411fe741cf003237064349e22 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-05 | 193 | 20 | 3 | 6e6c5ae39ea880ba809019a7d39f50e4e02007ed | |
| ToppCell | normal-na-Lymphocytic_B-B_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.40e-05 | 193 | 20 | 3 | 2fd1cc050c775360cd53872fd405cf78288d7c4d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-05 | 193 | 20 | 3 | c04ac5884be4245b75d211046f04d76ae0cfb998 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 8.40e-05 | 193 | 20 | 3 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-05 | 193 | 20 | 3 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 8.40e-05 | 193 | 20 | 3 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-05 | 193 | 20 | 3 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 8.40e-05 | 193 | 20 | 3 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.53e-05 | 194 | 20 | 3 | 24f9de4781666c96c4a2d04f8a444543dbd99cbe | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 8.53e-05 | 194 | 20 | 3 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | COVID-19_Moderate-B_naive|World / disease group, cell group and cell class | 8.53e-05 | 194 | 20 | 3 | 1f81d618799e482a36dce528bba70f52cc69a901 | |
| ToppCell | COVID-19_Severe-B_naive|World / disease group, cell group and cell class | 8.53e-05 | 194 | 20 | 3 | d363963a6caeedf4f9e9ad22dcf9b66b85c79a48 | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; HL60; HT_HG-U133A | 1.52e-05 | 186 | 19 | 4 | 2926_DN | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; HL60; HT_HG-U133A | 1.90e-05 | 197 | 19 | 4 | 2944_UP | |
| Disease | anti-GAD65 autoimmune neurological syndromes | 2.31e-04 | 35 | 19 | 2 | EFO_0803379 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 2.51e-04 | 194 | 19 | 3 | EFO_0004265, EFO_0007908 | |
| Disease | brain measurement, neuroimaging measurement | 3.70e-04 | 550 | 19 | 4 | EFO_0004346, EFO_0004464 | |
| Disease | breast milk measurement | 2.10e-03 | 106 | 19 | 2 | EFO_0009092 | |
| Disease | irritable bowel syndrome | 3.18e-03 | 131 | 19 | 2 | EFO_0000555 | |
| Disease | adiponectin measurement | 3.93e-03 | 146 | 19 | 2 | EFO_0004502 | |
| Disease | hemorrhoid | 3.99e-03 | 147 | 19 | 2 | EFO_0009552 | |
| Disease | Takayasu arteritis | 4.04e-03 | 148 | 19 | 2 | EFO_1001857 | |
| Disease | neuroimaging measurement | 4.30e-03 | 1069 | 19 | 4 | EFO_0004346 | |
| Disease | major depressive disorder | 4.42e-03 | 155 | 19 | 2 | MONDO_0002009 | |
| Disease | unipolar depression, bipolar disorder | 4.48e-03 | 156 | 19 | 2 | EFO_0003761, MONDO_0004985 | |
| Disease | cortical thickness | 4.96e-03 | 1113 | 19 | 4 | EFO_0004840 | |
| Disease | unipolar depression | 6.58e-03 | 1206 | 19 | 4 | EFO_0003761 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 7.25e-03 | 200 | 19 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Thyroid preparation use measurement | 8.48e-03 | 217 | 19 | 2 | EFO_0009933 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 9.24e-03 | 227 | 19 | 2 | EFO_0004346, EFO_0010736 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 9.32e-03 | 228 | 19 | 2 | EFO_0003948, MONDO_0004975 | |
| Disease | cortical surface area measurement | 9.62e-03 | 1345 | 19 | 4 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YHTRTLTLTHSHAHS | 146 | Q6ZRP5 | |
| HYHFSLHSVSHLLSS | 2586 | Q96M86 | |
| ASSLRSHHTHPSYGP | 641 | Q92997 | |
| FSSHGFSHYLLSHPS | 196 | Q8NHJ6 | |
| SLHPHERLSYPSHSS | 256 | P15884 | |
| RSSGSHSHSPSSHYR | 286 | O43312 | |
| HSHSPSSHYRYRSSN | 291 | O43312 | |
| SHRLAYHASSDPQHL | 286 | A6NMT0 | |
| RSSHSHSSSHKRFPS | 626 | Q9P2Q2 | |
| TFTQSHHHLPSRYSR | 386 | Q08AD1 | |
| TLVSAPHLARSYHHL | 311 | Q6P1K8 | |
| NHHSSAPSHSLFRAS | 351 | Q9BZY9 | |
| DHPLAHYFISSSHNT | 316 | Q15147 | |
| HSSSLASPARSHLYH | 1266 | Q92859 | |
| SRLHSSLHFSLPLFH | 1646 | Q8IVL1 | |
| AAHFYLHTSFSRPHT | 31 | Q9NRB3 | |
| AFPHSSSLRYHERTH | 376 | Q8IYI8 | |
| ASLSSHSSHLPIAHL | 1221 | A4D1E1 | |
| GHSPHSAYTTLLLHA | 186 | Q8WYR1 | |
| TLVSAPHLARSYHHL | 311 | Q13888 | |
| PSKPFHRSSHYHTSR | 491 | Q8N3Z6 | |
| HSSLHITASHPRDSA | 91 | A0A0B4J266 | |
| TSHSRLTHISPRHYG | 926 | Q9H7M6 |